Apr 16 2007, 8:30 AM EST
News source: Business Wire
Prasco Laboratories, a Cincinnati-based pharmaceutical company, announced today it has entered into a distribution and supply agreement with Graceway Pharmaceuticals, LLC. for an authorized generic version of MetroGel-Vaginal Gel (metronidazole vaginal gel, 0.75%). Prasco authorized generics are generic products manufactured by brand companies and marketed as generics under the Prasco label.
"We are extremely pleased to have established this marketing relationship with Graceway," said Prasco Chief Executive Officer E. Thomas Arington. "The Metronidazole product, like other Prasco authorized generics, benefits consumers by delivering brand quality at generic prices," Arington stated. Jefferson J. Gregory, Chairman and CEO of Graceway remarked "Prasco is an excellent and dynamic company and we are excited to have established this relationship with them."
Metronidazole Vaginal Gel is AB-rated and is indicated for the treatment of bacterial vaginosis. "It is one of many authorized generics Prasco plans to launch in 2007 as we continue to strengthen our leadership position in authorized generics," said Arington. "Prasco authorized generics provide additional competition, which benefits the consumer through lower prescription costs," Arington concluded.
Prasco began shipping its authorized generic version of MetroGel-Vaginal Gel last week.
About Prasco
Metronidazole Vaginal Gel 0.75% is the latest product from Prasco in its rapidly growing authorized generics program. Prasco's mission is to provide both quality products and significant cost-savings to the consumer. The company's goal is to provide patients with an identical brand experience through authorized generics. The Prasco product line is currently sold through the major distribution channels, including chains, independent pharmacies, distributors, wholesalers, and managed care providers.
The company operates its administrative office and warehouse facilities from Cincinnati, OH including DEA-approved facilities for Schedule II-V controlled drug products.
About Graceway
Graceway Pharmaceuticals, LLC.(TM) ( " Graceway " ), headquartered in Bristol, Tennessee, is a leading specialty pharmaceutical company focused on acquiring, in-licensing, and developing branded prescription pharmaceutical products in the dermatology, respiratory, and women's health markets, among others. Current prescription products marketed by Graceway include Aldara(R), Atopiclair(R), Benziq(R), Maxair(R), Minitran(R), and Tambocor(R). Aldara, Atopiclair, Benziq, Maxair, Tambocor, and Minitran are trademarks owned by or licensed to Graceway.
ADVERTISEMENT
INTERVIEW:
(BIO) BANKING IN LUXEMBOURG - Interview with Robert Hewitt, Ph.D., CEO, Integrated Biobank of Luxembourg, and European Editor, Biopreservation and Biobanking (published by Mary Ann Liebert, Inc.)
...MORE
NewsArticles Blogs| Most Viewed | Most Emailed | Top Searches |
|---|---|---|
| Unclog the Innovation Bottleneck at our Nation’s Universities | ||
| (Bio) Banking in Luxembourg | ||
ADVERTISEMENT
Subscribe to RSS
Email
Print
Share
More News
Listen
Save
Comment
View All